GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Maccura Biotechnology Co Ltd (SZSE:300463) » Definitions » E10

Maccura Biotechnology Co (SZSE:300463) E10 : ¥0.96 (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Maccura Biotechnology Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Maccura Biotechnology Co's adjusted earnings per share data for the three months ended in Sep. 2024 was ¥0.130. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.96 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Maccura Biotechnology Co's average E10 Growth Rate was -12.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-03), Maccura Biotechnology Co's current stock price is ¥13.40. Maccura Biotechnology Co's E10 for the quarter that ended in Sep. 2024 was ¥0.96. Maccura Biotechnology Co's Shiller PE Ratio of today is 13.96.

During the past 13 years, the highest Shiller PE Ratio of Maccura Biotechnology Co was 15.52. The lowest was 11.68. And the median was 13.37.


Maccura Biotechnology Co E10 Historical Data

The historical data trend for Maccura Biotechnology Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maccura Biotechnology Co E10 Chart

Maccura Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.95

Maccura Biotechnology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.10 0.95 0.96 0.95 0.96

Competitive Comparison of Maccura Biotechnology Co's E10

For the Diagnostics & Research subindustry, Maccura Biotechnology Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maccura Biotechnology Co's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Maccura Biotechnology Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Maccura Biotechnology Co's Shiller PE Ratio falls into.


;
;

Maccura Biotechnology Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Maccura Biotechnology Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.13/115.7848*115.7848
=0.130

Current CPI (Sep. 2024) = 115.7848.

Maccura Biotechnology Co Quarterly Data

per share eps CPI Adj_EPS
201412 0.110 99.000 0.129
201503 0.110 99.900 0.127
201506 0.157 99.500 0.183
201509 0.290 100.500 0.334
201512 0.103 100.600 0.119
201603 0.120 102.200 0.136
201606 0.180 101.400 0.206
201609 0.140 102.400 0.158
201612 0.120 102.600 0.135
201703 0.140 103.200 0.157
201706 0.210 103.100 0.236
201709 0.190 104.100 0.211
201712 0.141 104.500 0.156
201803 0.180 105.300 0.198
201806 0.238 104.900 0.263
201809 0.222 106.600 0.241
201812 0.167 106.500 0.182
201903 0.215 107.700 0.231
201906 0.274 107.700 0.295
201909 0.262 109.800 0.276
201912 0.192 111.200 0.200
202003 0.137 112.300 0.141
202006 0.420 110.400 0.440
202009 0.459 111.700 0.476
202012 0.408 111.500 0.424
202103 0.563 112.662 0.579
202106 0.392 111.769 0.406
202109 0.475 112.215 0.490
202112 0.289 113.108 0.296
202203 0.340 114.335 0.344
202206 0.333 114.558 0.337
202209 0.318 115.339 0.319
202212 0.174 115.116 0.175
202303 0.190 115.116 0.191
202306 0.096 114.558 0.097
202309 0.153 115.339 0.154
202312 0.072 114.781 0.073
202403 0.200 115.227 0.201
202406 0.129 114.781 0.130
202409 0.130 115.785 0.130

Add all the adjusted EPS together and divide 10 will get our e10.


Maccura Biotechnology Co  (SZSE:300463) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Maccura Biotechnology Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=13.40/0.96
=13.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Maccura Biotechnology Co was 15.52. The lowest was 11.68. And the median was 13.37.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Maccura Biotechnology Co E10 Related Terms

Thank you for viewing the detailed overview of Maccura Biotechnology Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Maccura Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
Number 8, 2nd Anhe Road, Hi-tech Zone, Chengdu, CHN, 611731
Maccura Biotechnology Co Ltd is a China-based in-vitro diagnostic (IVD) integration company engaged in the research and development, production and sales of IVD products. It is also engaged in the sales of foreign brands of in vitro diagnostic products as an agent. The company's developed product and technology development platforms cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.
Executives
Guo Lei Director
Wang Deng Ming Directors, executives
Wang Lin Supervisors
Wu Ming Jian Directors, executives
Shi Wei Directors, executives
Yang Hui Supervisors
Zhou Yue Guo Executives
Wang Zhen Executives
Yu Ping Executives
Zou Yuan Supervisors
Xu Sheng Guo Directors, executives
Liu Qi Lin Directors, executives
Chu Jian Jun Executives
Tang Yong Director
Xu Jin Song Executives

Maccura Biotechnology Co Headlines

No Headlines